Comments on: Biogen Presents Positive Results from Phase 2 IGNAZ Study of Felzartamab in IgA Nephropathy at American Society of Nephrology (ASN) Kidney Week 2024 https://thegbm.com/biogen-presents-positive-results-from-phase-2-ignaz-study-of-felzartamab-in-iga-nephropathy-at-american-society-of-nephrology-asn-kidney-week-2024/ Business news, opinion, reviews, interviews Sun, 27 Oct 2024 00:15:00 +0000 hourly 1 https://wordpress.org/?v=6.6.2